Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.

Blood - 1 May 2004

Lech-Maranda Ewa, Baseggio Lucile, Bienvenu Jacques, Charlot Carole, Berger Françoise, Rigal Dominique, Warzocha Krzysztof, Coiffier Bertrand, Salles Gilles

Abstract excerpt

The aim of the study was to investigate whether interleukin-10 (IL-10) genetic polymorphisms influence this cytokine production as well as the incidence and outcome of diffuse large B-cell lymphoma (DLBCL). The frequency of IL-10(-1082G) allele was found to be higher in 199 patients with DLBCL as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interleukin-10
Share to Lymphoma, B-Cell
Share to Lymphoma, Large B-Cell, Diffuse

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Remission Induction

Share to Survival Analysis

Share to Treatment Outcome

Source

Identifiers

PMID: 14701701
DOI: 10.1182/blood-2003-06-1850

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14701701-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.PMID 14701701Read ↗

Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.Semantic proximity Read ↗

Impact of SNPs/Haplotypes of IL10 and IFNG on the Development of Diffuse Large B-Cell Lymphoma.Semantic proximity Read ↗

Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas.Semantic proximity Read ↗

Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.Semantic proximity Read ↗

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.Semantic proximity Read ↗

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.Semantic proximity Read ↗

Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOPSemantic proximity Read ↗

Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.Semantic proximity Read ↗

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.Semantic proximity Read ↗

Interleukin‐10 gene polymorphisms influence the clinical course of non‐Hodgkin’s lymphomaSemantic proximity Read ↗

Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.